From GRAS to Grassroots: RFK Jr.’s Fight Against FDA Corruption

Quick Overview of the Story

• The U.S. Food and Drug Administration, established in 1906 to safeguard public health, saw its original mission compromised when food industry lobbyists ousted its first head, Harvey Wiley, who had staunchly opposed harmful food additives.
• Under the FDA’s “Generally Recognized as Safe” (GRAS) label, a plethora of potentially dangerous food additives have infiltrated our food supply. Astonishingly, about 99% of new food chemicals introduced since 2000 have bypassed rigorous safety checks by exploiting this loophole.
• The FDA has often resisted natural treatments such as DMSO, which has shown promise for managing pain, neurological issues, and injuries, along with raw milk and select stem cell therapies, while it has endorsed potentially hazardous pharmaceutical options.
• Notable FDA-related vaccine controversies include the 1955 polio vaccine incident involving SV40 virus contamination, the 1976 swine flu vaccine linked to Guillain-Barré Syndrome, and the Gulf War Syndrome associated with mandatory experimental vaccines. More recent contentious FDA decisions involve approving SSRI antidepressants, despite their association with increased suicide risk, Alzheimer’s drugs with severe side effects, and the weight loss drug Ozempic, which lacks comprehensive long-term safety data.
• Proposed changes to the FDA’s operations include establishing distinct approval pathways for conventional versus alternative treatments, enforcing stricter conflict of interest policies, making clinical trial data accessible to the public, and developing more effective methods to withdraw approvals from drugs that prove harmful.

As an integrative medicine doctor, I am beyond frustrated with the continuous abuses by the FDA. For years, I’ve witnessed the agency prioritize the interests of Big Pharma over public health, allowing numerous potentially harmful food additives through the GRAS loophole without thorough safety assessments. This negligence directly contradicts the principles of holistic health I strive to uphold. When I see patients suffering from conditions exacerbated by these additives, it’s infuriating to know that the FDA’s lax regulations could have been a contributing factor. Their resistance to natural therapies like DMSO, which has demonstrated benefits in my practice for pain and healing, only adds to this frustration. It feels like the FDA is more interested in protecting corporate profits than in fostering genuine health advancements.

Moreover, the FDA’s history of controversial drug approvals, like SSRI antidepressants and questionable Alzheimer’s treatments, makes me angry. These decisions often come with known risks, yet the agency pushes them forward, seemingly ignoring the potential harm. The lack of transparency and the apparent conflict of interest within the FDA’s approval processes is a slap in the face to every practitioner trying to heal patients with a whole-person approach. We need reforms, not just for the sake of alternative medicine but for all medicine. The current system undermines the trust patients place in us, and it’s disheartening to battle against an institution meant to protect health but instead seems to endanger it.

Robert F. Kennedy Jr. has been appointed to lead the FDA, an agency that has come under scrutiny for its regulatory practices. Known for his skepticism towards vaccine safety and his advocacy for environmental health, Kennedy is expected to initiate significant reforms. His agenda includes tackling what he perceives as corruption within the FDA, particularly focusing on eliminating the influence of pharmaceutical and food industries on agency decisions. He has indicated intentions to remove certain departments he deems ineffective, such as the FDA’s nutrition division, and to overhaul the approval processes to ensure they are not swayed by industry funding. His plans also involve revisiting the “Generally Recognized as Safe” (GRAS) designations for food additives and pushing for more transparency and independence in drug and vaccine safety assessments.

Can RFK Jr. accomplish his goals? Let’s review the historical record of the FDA and consider the challenges he faces.

Understanding Sensitivity and Specificity in Medical Testing

In the realm of medicine, “sensitivity” describes a test’s capacity to accurately pinpoint individuals who possess a specific condition, such as an infection. On the other hand, “specificity” evaluates how well a test can exclude false positives, thereby correctly identifying those without the condition. However, enhancing one aspect generally compromises the other, presenting a significant challenge.

For instance, elevating the PCR cycle threshold in COVID tests increases the likelihood of detecting infections, enhancing sensitivity, but at the cost of more false positives, thus reducing specificity. This trade-off manifests in scenarios like breast cancer screenings, where high sensitivity might lead to unnecessary interventions for women who are actually cancer-free.

The FDA’s Balancing Act

The FDA faces a parallel dilemma: it must safeguard against harmful foods and drugs reaching consumers while ensuring that beneficial products aren’t unjustly blocked. Despite the apparent simplicity of this task, it’s fraught with complexity, and the FDA has often stumbled in both areas, even with leaders committed to public welfare.

Crime Against the Food Law

Historical Context and Public Outcry

During the late 19th century, food producers were notorious for selling adulterated goods, while pharmaceutical companies marketed medicines with undisclosed ingredients like opium and alcohol. The public’s outrage was fueled by exposés like Upton Sinclair’s “The Jungle,” which catalyzed the 1906 Pure Food and Drug Act. This legislation empowered the Bureau of Chemistry (precursor to the FDA) to enforce accurate labeling and prevent the use of harmful additives in food.

Harvey Wiley’s Battle

Harvey Wiley, the first head of what would become the FDA, conducted experiments demonstrating the adverse effects of food additives on volunteers. Despite support from the public and scientific community, the food industry retaliated with aggressive lobbying and legal strategies.

The Industry’s Influence

By 1912, the increasing influence of food industry lobbyists led to Wiley’s resignation, believing he could make more impact outside government. His book, “The History of a Crime Against the Food Law,” details these tactics, which are echoed today as the processed food industry reportedly works to undermine RFK’s nomination and health reform initiatives.

Generally Recognized as “Safe”

The GRAS Loophole

Many food additives fall under the “generally recognized as safe” (GRAS) category, allowing them to be used without stringent regulation. Wiley tackled both counterfeit food production and harmful additives. The industry often resorted to deceptive practices like diluting whiskey with grain alcohol or using contaminated water to bulk up oysters.

Despite evidence of harm, the food industry argued these additives were necessary for production, a claim refuted by competitors producing high-quality goods without them. Wiley warned of the long-term health risks from chronic exposure to such additives, including organ damage and premature aging.

Note: Since 2000, nearly 99% of new food chemicals have entered the market through the GRAS loophole.

Modern Implications

I believe the pervasive use of aluminum in processed foods is especially harmful, as it disrupts the body’s zeta potential, leading to micro-clotting. This might explain why some individuals experience rapid health improvements upon eliminating processed foods from their diet.

The Kefauver-Harris Amendment

After Harvey Wiley’s exit, the FDA’s ability to regulate was further compromised. When thalidomide, a drug for morning sickness, was under review, an FDA agent could only delay its approval, not outright reject it, thereby averting a disaster of birth defects in the U.S. This event led to the passage of the 1962 Kefauver-Harris Amendment, which vested the FDA with the authority to prevent the marketing of unsafe drugs.

Impacts on Drug Development

This amendment significantly increased the FDA’s regulatory power, inadvertently slowing down drug approvals and leading to mismanagement. Among its stipulations was the requirement for “well-controlled” trials, which the FDA interpreted as costly double-blind randomized controlled trials (RCTs). This:

• Increased Costs: Made drug approval a “pay-to-play” scenario, with expenses for each new drug skyrocketing to between $0.98 billion and $4.54 billion.
• Introduced Bias: With such high costs, RCTs often yield results favorable to their sponsors, potentially overshadowing the benefits of their rigorous “controlled” design.
• Neglected Alternative Research: Dismissed smaller, yet effective observational studies, which could provide similar results at a fraction of the cost, as evidenced by a 2014 Cochrane Review.
• Hindered Innovation: Stifled new, unconventional treatments due to the financial barrier of RCTs, leading to a slowdown in medical innovation in the U.S., with scientists pressured to conform rather than innovate.

The FDA’s expansion into areas it was unprepared for led to frequent failures in fulfilling its core duties, like removing harmful products from the market, while also blocking access to treatments the public desired.

Congressional and Public Backlash

This mismanagement sparked numerous investigations, including Commissioner Ley’s Kinslow report on the agency’s deficiencies, and resulted in the ousting of ethical officials like Ley himself. The New York Times published a series of critical articles in 1977 highlighting these issues. Despite various efforts by Congress and ethical FDA officials to rectify the situation, no lasting solutions were achieved, making the FDA one of the most criticized government agencies.

The DMSO Saga

In recent months, I’ve delved into the overlooked world of DMSO, a natural chemical known for its effectiveness against a myriad of conditions, many deemed “incurable”:

• Neurological and Circulatory: Effective for strokes, paralysis, Down Syndrome, dementia, and circulatory disorders like Raynaud’s and varicose veins.
• Pain and Injury: Offers relief for chronic pain from conditions like disc issues, arthritis, and complex regional pain syndrome, alongside healing sprains, concussions, burns, and surgical incisions.
• Autoimmune and Other Disorders: Treats scleroderma, amyloidosis, and interstitial cystitis.
• Head-Related Conditions: Helps with tinnitus, vision loss, dental problems, and sinusitis.
• Internal Organ Diseases: Beneficial for pancreatitis, infertility, and liver cirrhosis.
• Skin Conditions: Useful for acne, herpes, hair loss, and varicose veins.

The FDA’s Stance on DMSO

Despite its potential to reduce opioid use and alleviate the suffering of millions from strokes and spinal injuries, DMSO remains unknown to many. Initially welcomed by the FDA in the 1960s, the agency later reversed its stance, labeling DMSO as hazardous without substantial evidence, largely to manage the influx of new drug applications and protect pharmaceutical interests.

Even with extensive safety studies proving DMSO’s safety, the FDA continued to suppress it, citing a lack of efficacy evidence, which was hard to prove due to DMSO’s unique properties making blind trials impractical. Only after public frustration with FDA’s regulation of natural medicines led to the 1994 Dietary Supplement Health and Education Act, which curtailed the FDA’s oversight of natural remedies, did DMSO become more accessible.

The FDA’s War Against Natural Medicine

Shortly before the election, RFK Jr. gave one of the most important statements on X in the entire campaign:

“FDA’s war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals and anything else that advances human health and can’t be patented by Pharma. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.”

The AMA and FDA’s Suppression of Natural Therapies

A recent tweet highlighted how the American Medical Association (AMA) has historically worked to eliminate effective natural therapies that challenge the medical establishment’s dominance. The FDA has mirrored these actions:

GHB (Gamma-Hydroxybutyrate)

• In the 1990s, GHB emerged as a natural, life-altering sleep aid that effectively treated insomnia across America. However, the FDA banned it, contrasting with sleeping pills which disrupt restorative sleep—essential for health—and increase mortality risk by 2 to 5 times.

Psychedelic Therapy

• MDMA-assisted psychotherapy has proven to be the most effective treatment for PTSD in veterans, yet the FDA has not approved it, blocking access based on the requirement for “controlled” clinical trials. As a result, veterans are forced to travel abroad for this therapy.

Chelation Therapy

• EDTA chelation therapy, particularly at low doses, shows promise for cardiovascular health, yet the FDA has continually targeted it. This is despite the NIH’s reluctant acknowledgment of its effectiveness.

Umbilical Cord Blood Stem Cells

• Under Biden’s administration, FDA regulations have made it challenging for companies to offer umbilical cord blood stem cell therapy, limiting access to this potentially transformative treatment.

Sunlight and Health Risks

• The dermatology sector has exaggerated claims linking sunlight to skin cancer, ignoring its benefits for overall health and cancer prevention. Studies suggest that those who avoid sunlight have a 60% to 130% higher mortality rate.

Raw Milk Controversy

• The FDA has historically pursued legal actions against raw milk producers, despite consumer demand and evidence that pasteurization destroys beneficial nutrients and can turn milk into an allergenic substance.

Infant Formula and Seed Oils

• The Infant Formula Act of 1980 requires including seed oils in baby formulas, which could be linked to childhood obesity by impairing metabolism and encouraging rapid weight gain.

Vaccine Coverups

Betrayal of Public Trust

• The public has expressed horror upon learning that the FDA and CDC seemingly overlooked or ignored numerous warning signs regarding the safety of the COVID vaccines, aggressively promoting them despite evidence of harm. Leaked recordings have revealed the head of the FDA’s vaccine division staunchly refusing to acknowledge concerns raised by those permanently injured by vaccines.

Historical Context

• This isn’t an isolated incident but an extension of a long-standing pattern where the government has pushed vaccines known to be unsafe or ineffective. The question “How could this have happened?” is rooted in this history of regulatory overreach and neglect of public safety for broader agendas.

Vaccine Coverups and Failures by the FDA and CDC

Historical Vaccine Disasters

• Numerous vaccine-related issues have been either ignored or covered up by health authorities, including several lethal “hot lot” incidents where certain batches of vaccines caused unusually high adverse reactions.

Polio Vaccine Issues

• In the 1950s, the rush to produce a polio vaccine led to some batches containing live polio viruses, resulting in cases of paralysis. Later, it was revealed that these vaccines were contaminated with SV40, a cancer-causing virus, which was not disclosed to the public. This exposure potentially affected between 40 to 98 million Americans, leading to a significant increase in cancer incidences.

Influenza Vaccine Failures

• In 1945, a government scientist uncovered that early flu vaccines were both ineffective and unsafe; however, this led to retaliation against the scientist, and the vaccines were distributed anyway. This prompted a 1972 Senate hearing which resulted in the removal of 32 questionable vaccines from the market.

Swine Flu Vaccine Disaster (1976)

• Despite evidence indicating the swine flu posed little risk, the vaccine was released, leading to numerous cases of Guillain-Barré syndrome, paralysis, and deaths. The FDA had been warned by its own scientists about the vaccine’s safety but chose to proceed, paralleling the transparency issues seen during the COVID-19 vaccine rollout.

Gulf War Syndrome

• During the Gulf War, protections for soldiers against experimental drugs were waived. Soldiers received multiple vaccines, including a hastily produced anthrax vaccine, which was contaminated. This resulted in Gulf War Syndrome, affecting approximately 250,000 veterans. Mandatory use of this vaccine persisted until a 2004 court ruling stopped it.

HPV Vaccine Controversy

• The HPV vaccine was approved despite concerning clinical trial data showing high rates of autoimmunity, deaths, and even instances where it caused cervical cancer. After market release, the surge in injuries was met with continued promotion by the FDA and CDC.

Other Disastrous Drug Approvals

SSRI Antidepressants

• SSRIs, like Prozac, were approved despite weak evidence of effectiveness and known severe side effects, including suicidal behavior, emotional blunting, and links to violent acts. These risks were not communicated to the public, later leading to numerous lawsuits.

Alzheimer’s Drugs

• A class of Alzheimer’s drugs was approved despite failing to demonstrate efficacy and causing serious side effects such as brain swelling and bleeding in a significant number of trial participants. The FDA’s decision to approve these drugs, against advisory committee advice, sparked considerable controversy.

Ozempic and Weight Loss Drugs

• The FDA’s approval of weight loss drugs like Ozempic came without robust long-term safety data, yet the drugs were heavily marketed, including for pediatric use, despite safety concerns.

Conclusion

The FDA has a documented history of approving vaccines and drugs that are unsafe or ineffective, often prioritizing corporate interests over public health.

Core Issues with the FDA

1. Insufficient Resources: The task of regulating food and drugs in the U.S. is overwhelming for the FDA’s current capacity.
2. Corruption and Conflicts of Interest: The FDA’s reliance on pharmaceutical companies for drug safety assessments creates a biased approval process.
3. Lack of Accountability: Once drugs are approved, there’s little recourse even when harm is evident.
4. Selective Prosecution: The FDA tends to target natural remedies over pharmaceuticals due to less industry pushback.

Proposed Solutions for Reform

1. Conflict of Interest Laws: Nullify decisions made by officials with financial ties to drug companies.
2. Separate Approval Tracks: Establish distinct regulatory pathways for conventional versus alternative treatments.
3. Market-Driven Efficacy: Let market demand dictate a drug’s perceived effectiveness.
4. Public Involvement: Use AI and public input to analyze patient data for safety signals.
5. Transparent Data Access: Publicly disclose all drug trial data to prevent fraud or manipulation.
6. Revocation of Drug Approvals: Allow for easier withdrawal of harmful drugs from the market.

With social media platforms now challenging traditional media’s control over public discourse, these reforms might be achievable, but as Wiley warned, public engagement is crucial for change, which movements like MAHA are now facilitating.